China’s drug regulator clears mpox vaccine

Beijing, Sep 10: China’s top drug regulator has cleared a mpox vaccine developed by local drug firm Sinopharm for clinical trials which could be the country’s first experimental dose to battle the deadly disease.

The domestic vaccine candidate, created by the Shanghai Institute of Biological Products and administered by Sinopharm, is expected to play an important role in preventing and controlling mpox infections, the company said in a statement released on Monday afternoon.

There is currently no approved mpox vaccine in China. Globally, a few vaccines have been approved in the United States, Canada, the European Union, Japan and Russia.

In China, a vaccine candidate typically goes through three phases of clinical trials before gaining market approval.

The process can take years, even decades. However, the National Medical Products Administration, China’s top drug regulator, has launched a number of accelerated or streamlined channels to facilitate applications of novel drugs and vaccines or those in urgent need, state-run China Daily reported on Tuesday.

According to the company, the new vaccine is a replication-deficient vaccine based on a strain called MVA.

The description is the same as Jynneos, the world’s first mpox vaccine approved by the Food and Drug Administration in the United States in 2019.

The World Health Organisation said on August 14 that the mpox outbreak in Africa constitutes a public health emergency of international concern — its highest form of alert.

Previously, in July 2022, the WHO declared a global emergency but then lifted it in May last year because of a sustained decline in international cases.

So far, more than 120 countries and regions across the world have reported more than 100,000 confirmed infections and 226 related deaths.

China reported its first imported case in September 2022 and the first domestic case in June last year.

By the end of July, the nation had reported 2,567 confirmed cases, according to the China Daily report. (PTI)

Hot this week

Pay hike of Assam ministers, MLAs likely as 3-member panel submits report

Full report likely by Oct 30 Guwahati Sept 25: There...

Meghalaya Biological Park Inaugurated After 25 Years: A New Chapter in Conservation and Education

Shillong, Nov 28: Though it took nearly 25 years...

ANSAM rejects Kuki’s separate administration demand, says bifurcation not acceptable

Guwahati, Sept 8: Rejecting the separate administration demand of...

Meghalaya man missing in Bangkok

Shillong, Jan 10: A 57-year-old Meghalaya resident, Mr. Treactchell...

Meghalaya’s historic fiber paves the way for eco-friendly products and sustainable livelihoods

By Roopak Goswami Shillong, Oct 25: From making earbuds to...

Prez Murmu felicitates Durand Cup champions NEUFC

New Delhi, Aug 27: President Droupadi Murmu on Wednesday...

Paul emphasises equal opportunities for PwDs

Shillong, Aug 27: Social Welfare minister Paul Lyngdoh stressed...

Six dead as unauthorised building collapses in Virar, Maharashtra

Palghar, Aug 27: Six persons were killed and eight...

Shah Rukh Khan, Deepika Padukone booked in Bharatpur for ‘defective’ car

Jaipur, Aug 27: Police in Rajasthan's Bharatpur have registered...

Govt depts asked to verify Aadhaar with QR scanner

Shillong, Aug 27: The General Administration Department has issued...

Govt launches Online Building Permission System

Shillong, Aug 27: The state government has notified the...

300 SSA schools keen to hand over management to Govt

Proposal for pay scale structure for 14,000 SSA teachers...

Anish Bhanwala wins 25m rapid fire pistol silver at Asian C’ships

Shymkent (Kazakhstan), Aug 27: India's Anish Bhanwala once again...
spot_img

Related Articles

Popular Categories